[Primary shape change of platelets in vitro (author's transl)].
Studies with interference contrast microscopy reveal that platelets undergo a typical shape change within 30--60' after venepuncture, i.e. swelling, formation of large tentacles, tiny protrusions and vesicles at the platelet surface. This "shape change" can be observed in citrated blood and PRP, heparinized blood and EDTA-blood as well. It is enhanced by low incubation temperatures (4 degrees C, 10 degrees C) and delayed at 37 degrees C as compared with room temperature. An increased number of primarily shape changed platelets is found if platelets are strongly mechanically irritated at blood sampling. The shape change is partly reversible in vitro, it is completely or almost completely reversible in vivo. Some antiaggregating agents inhibit the in vitro shape change at varying degrees (Bencyclan, SH 869  greater than ASA greater than D-Propranolol). The shape change is partly inhibited after oral or i.v. administration of ASA. A typical transformation of platelets into "spheric" forms can be observed following the addition of Bencyclan, SH 869 and D-Propranolol to PRP in vitro. The spontaneous "primary shape change" which occurs in PRP or blood after blood sampling is probably different from the secondary ADP-induced shape change. The primary shape change may influence the results of different platelet function and aggregating tests. The shape change kinetics of "healthy" subjects and patients with Hodgkin's disease differ significantly. The described method may gain more clinical interest in the future.
D001241:Aspirin / Q000494:pharmacology; D001537:Bencyclane / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects; D005260:Female; D006689:Hodgkin Disease / Q000097:blood; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008857:Microscopy, Interference; D011433:Propranolol / Q000494:pharmacology; D013499:Surface Properties; D013696:Temperature; D013997:Time Factors
D001537:Bencyclane; D011433:Propranolol; D001241:Aspirin
Primärer Formwandel der Thrombozyten in vitro.